Canbiola is Registered and Active in the GSA's System for Award Management (SAM) and Department of Defense (DOD)
March 11 2019 - 12:14PM
InvestorsHub NewsWire
Canbiola is Registered and Active in the GSA's System for Award
Management (SAM) and Department of Defense (DOD)
Widens the Availability of its CBD
Products
Hicksville, NY -- March 11, 2019 -- InvestorsHub NewsWire --
Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the
“Company”), a developer, manufacturer and seller of a
variety of Cannabidiol (Hemp) based products such as oils, creams,
moisturizers, chews, isolate, gel caps, and concentrate, announced
today that it is now registered and active in the U.S.
government GSA’s System for Award Management (SAM) and Department
of Defense (DOD).
The System for Award Management (SAM) is an official website of
the U.S. government. There is no cost to use SAM. GSA’s Office of
Government-wide Policy is consolidating federal procurement and
award systems into 1 new system—the System for Award
Management (SAM). SAM is streamlining processes, improving data
quality by eliminating the need to enter the same data multiple
times, and consolidating hosting to save taxpayer money.
The registration number for Canbiola, Inc. is 789110553 / 5C7D3
and is now active in the U.S. federal government's System for Award
Management (SAM/DOD).
For additional information, please visit:
https://www.sam.gov/SAM/
https://www.acq.osd.mil/dpap/pdi/eb/system_for_award_management.html
Canbiola Chief Executive Officer Marco Alfonsi, commented,
“Attaining SAM and DOD registration is quite an accomplishment and
something our team at Canbiola had been working on for some time.
We are proud to now be active in the system, which enables our
products to be more widely available to those who seek CBD
solutions. We look forward to being an active participant in the
U.S. government program.”
About Canbiola, Inc.
Canbiola, Inc. (OTCQB: CANB) is a developer,
manufacturer and seller of a variety of Cannabidiol (Hemp) based
products such as oils, creams, moisturizers, chews,, isolate, gel
caps, and concentrates. Canbiola has developed its own line of
proprietary products as well as seeking synergistic value through
acquisitions in the CBD and the medical cannabis industry. Cannabis
is currently federally illegal and has legalized for medical
purposes in some form in a limited number of states, but pure CBD
products are legal in all 50 states. Hemp CBD is the
non-psychoactive component (No THC) used for treatment of pain,
inflammation, and wellness programs. For more
information about Canbiola, Inc., please
visit: https://canbiola.com.
Additionally, Canbiola’s wholly owned subsidiary Pure Health
Products, based in Lacey, WA, is its prime development laboratory
and production facility. Canbiola’s Duramed division has
recently rolled out a durable medical device via its Doctor network
to treat patients with injuries via application of an in-home
ultrasound sustained acoustic device for pain and inflammation
reduction.
Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed
in this letter contain forward-looking statements. The words
"anticipate," "believe," "estimate," "may," "intend," "expect," and
similar expressions identify such forward-looking statements.
Expected, actual results, performance, or achievements could differ
materially from those contemplated, expressed, or implied by the
forward-looking statements contained herein. Forward-looking
statements are subject to a number of risks and uncertainties,
including but not limited to, risks and uncertainties associated
with, among other things, the impact of economic, competitive, and
other factors affecting our operations, markets, products, and
performance. The matters discussed herein should not be construed
in any way, shape or manner of our future financial condition or
stock price.
Follow Canbiola on:
Twitter @CanbiolaHealth
Instagram @canbiola.inc or @canbiola_cbd or
@canbiola_medical_cbd
Follow us on Twitter and Facebook
Investors and Media:
IR@canbiola.com
(516) 595-9544
Hayden IR
hart@haydenir.com
(917) 658-7878
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Aug 2024 to Sep 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Sep 2023 to Sep 2024